INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹16 Cr | ₹17 Cr | ₹12 Cr | ₹12 Cr | ₹18 Cr |
What is the latest Total Current Liabilities ratio of INDO US BIOTECH ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹16 Cr |
| Mar2024 | ₹17 Cr |
| Mar2023 | ₹12 Cr |
| Mar2022 | ₹12 Cr |
| Mar2021 | ₹18 Cr |
How is Total Current Liabilities of INDO US BIOTECH Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹16 Cr | -6.44 | |
| Mar2024 | ₹17 Cr | 42.06 | |
| Mar2023 | ₹12 Cr | 0.70 | |
| Mar2022 | ₹12 Cr | -32.03 | |
| Mar2021 | ₹18 Cr | - | |
Compare Total Current Liabilities of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹165.8 Cr | -2.6% | -6.7% | -51.5% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,023.6 Cr | -6% | -14.1% | -28.9% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,118.2 Cr | 0.2% | 5% | -3.8% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,083.2 Cr | 1.6% | 1% | -6% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹933.9 Cr | 0.1% | 0.8% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹523.0 Cr | -3% | -3.9% | -8% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -2.6% |
-6.7% |
-51.5% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses